1. 德晋贵宾厅

    B-hTAU*P301S mice

    C57BL/6JNifdc-Igs2tm1(Prnp-MAPT*P301S)Bcgen/Bcgen • 112927

    B-hTAU*P301S mice

    Product nameB-hTAU*P301S mice
    Catalog number112927
    Strain nameC57BL/6JNifdc-Igs2tm1(Prnp-MAPT*P301S)Bcgen/Bcgen
    Strain backgroundC57BL/6JNifdc
    NCBI gene ID17762 (Human)
    AliasesTau; Mtapt; PHF-tau
    ApplicationThis product is used for pharmacodynamics evaluation of Alzheimer's disease (AD).

    在此页面上

    • Description
    • Targeting strategy
    • Phenotypic analysis

    海报

    查看全部

      发表文章

        Description
        • TAU is mainly distributed in the central nervous system, most of it exists in the axons of neurons, and a small amount exists in oligodendrocytes. TAU is involved in neurodegenerative diseases, and most prominently in the pathogenesis of Alzheimer disease (AD).
        • Gene editing strategy: The full coding sequences of human TAU gene including the P301S mutation that is driven by mouse Prnp promoter are inserted into mouse Hipp11 (H11) locus in B-hTAU*P301S mice.
        • mRNA expression analysis: Mouse Tau mRNA were detectable in wild-type C57BL/6 mice and heterozygous B-hTAU*P301S mice, Human TAU mRNA was detectable only in heterozygous B-hTAU*P301S mice but not in wild-type mice. Sequence assays showed the heterozygous B-hTAU*P301S mice consists of a C to T point mutation at amino acid 301.
        • Protein expression analysis: TAU and p-tau were detected in cortex and hippocampus of both wild-type C57BL/6 mice and homozygous B-hTAU*P301S mice. Additionally, homozygous B-hTAU*P301S mice showed a significant increase in TAU and p-tau levels compared to wild-type C57BL/6 mice.
        Targeting strategy

        Gene targeting strategy for B-hTAU*P301S mice. The full coding sequences of human TAU gene with P301S mutation that is driven by mouse Prnp promoter are inserted into mouse Hipp11 (H11) locus in B-hTAU*P301S mice.

        Protein expression analysis

        Western blot analysis of phosphorylation of TAU protein expression in homozygous B-hTAU*P301S mice. Cortex and hippocampus lysates were collected from wild-type C57BL/6J mice (+/+) and homozygous B-hTAU*P301S mice (H/H, 12-week-old mice, n=2), and then analyzed by western blot (Phospho-Tau (Ser202, Thr205) antibody: Invitrogen, MN1020; anti-TAU antibody: CST, #46687). 20 μg total proteins were loaded for western blotting analysis. TAU and p-tau were detected in cortex and hippocampus of both wild-type and homozygous mice.

        mRNA expression analysis in B-hTAU*P301S mice

        Strain specific analysis of TAU mRNA expression in wild-type C57BL/6 mice and heterozygous B-hTAU*P301S mice by RT-PCR. Brain RNA were isolated from wild-type C57BL/6 mice (+/+) and heterozygous B-hTAU*P301S mice (H/+), and then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human TAU primers. As control, a group without reverse enzyme was also set. Mouse TAU mRNA was detectable both in wild-type C57BL/6 and heterozygous mice. Human TAU mRNA was detectable only in heterozygous B-hTAU*P301S mice but not in wild-type mice.

        * When publishing results obtained using this animal model, please acknowledge the source as follows: The animal model [B-hTAU*P301S mice] (Cat# 112927) was purchased from Biocytogen.